Economic burden of selected adverse events in patients aged ≥65 years with metastatic renal cell carcinoma

Author： Hagiwara May Hackshaw Michelle D. Oster Gerry

ISSN： 1369-6998

Source： Journal of Medical Economics, Vol.16, Iss.11, 2013-11, pp. : 1300-1306

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Continuous Therapy with Sunitinib in Patients with Metastatic Renal Cell Carcinoma

Oncology Research and Treatment, Vol. 31, Iss. 8-9, 2008-07 ,pp. : 485-485

Karger

Access to resources Recommend Favorite

Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 919-8172, Iss. 10, 2015-10 ,pp. : 888-897

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 888-897

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of metastatic breast cancer in women aged 65 years and older

By Jolly Trevor Williams Grant R Jones Ellen Muss Hyman B

Women's Health, Vol. 8, Iss. 4, 2012-07 ,pp. : 455-471

Future Medicine

Access to resources Recommend Favorite

Economic burden of cardiovascular events and fractures among patients with end-stage renal disease

By Doan Quan V. Gleeson Michelle Kim John Borker Rohit Griffiths Robert Dubois Robert W.

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1561-1569

Informa Healthcare

Access to resources Recommend Favorite